🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Nuvation Bio Inc.

NUVB Healthcare
$3.9 +$0.01 (0.13%)
Market Cap: $1.38 B
Gurus Holding
8
Popularity Rank
#873
% of Shares Held
2.27%
Net Activity (Q3 2026)
-$9.71 M

Guru Ownership Trend

Guru Analysis for Nuvation Bio Inc. (NUVB)

Nuvation Bio Inc. (NUVB), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2026, a total of 8 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $31.22 M.

Top institutional holders include Cliff Asness and Stanley Druckenmiller.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $9.71 M net outflow during the quarter.

Recent activity highlights Paul Tudor Jones who opened a new position. Conversely, Stanley Druckenmiller reduced exposure by 50.0%.

Key Holders

Recent Activity Breakdown (Q3 2026)

+$3.52 M
Total Buy Value
New Buys 2
Additions 1
-$13.23 M
Total Sell Value
Reductions 3
Sold Out 0

Guru Consensus (Q3 2026)

Based on recent activity
Net Sellers
3
Net Buyers
3

FAQs for Nuvation Bio Inc. (NUVB)

Major holders include Cliff Asness ($14.05 M), Stanley Druckenmiller ($12.71 M), Renaissance Technologies (RenTech) ($7.39 M). According to the latest reported data, 8 tracked investment managers collectively hold approximately 8 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $9.71 M, with 3 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 3 managers trimmed their positions, while 0 fully exited NUVB. The total reported sell value was $13.23 M.

Yes, 2 managers opened new positions in NUVB, and 1 increased their existing holdings. The total reported buy value was $3.52 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Add 6.4% 2,508,296 $14.05 M Q3 2026
0.28% Reduce -50.0% 2,269,900 $12.71 M Q3 2026
0.01% Reduce -2.0% 1,319,695 $7.39 M Q3 2026
0.15% 1,270,504 $7.11 M Q3 2026
0.00% New Buy 267,032 $1.5 M Q3 2026
0.25% New Buy 210,000 $1.18 M Q3 2026
0.00% Reduce -36.6% 115,480 $646,688 Q3 2026
0.01% 34,995 $195,972 Q3 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form